Morphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkey

  • Colak, Dilsen (Department of Oncology Medical, Diskapi Yildirim Beyazit Education and Training Hospital) ;
  • Oguz, Arzu (Department, Oncology Medical Baskent University) ;
  • Yazilitas, Dogan (Department of Oncology Medical, Numune Education and Research Hospital) ;
  • Imamoglu, Inanc Goksen (Department of Oncology Medical, Diskapi Yildirim Beyazit Education and Training Hospital) ;
  • Altinbas, Mustafa (Department of Oncology Medical, Diskapi Yildirim Beyazit Education and Training Hospital)
  • Published : 2014.06.30


Background: In Muslim majority countries (MMC) opioid use for pain management is extremely low. The underlying factors contributing to this are not well defined. Aim: The aim of this study was to survey the attitudes of cancer patients towards morphine use for pain management in a MMC and identify the factors that influence patient decisions to accept or refuse morphine as treatment for cancer pain. Settings/participants: Patients were questioned whether they had pain or not, the severity and the medications for pain management. Questions included what type of medication they thought morphine was, whether or not they would be willing to take morphine if recommended for pain management and the basis for their decision if they were against morphine use. Results: Four hundred and eighty-eight patients participated in the study. Some 50% of the patients who refused morphine use and 36.8% of the patients who would prefer another drug, if possible, identified fear of addiction as the basis for their decision. Reservation of morphine for later in their disease was the case for 22.4% of the patients who refused morphine use. Only 13.7 % of the patients refusing morphine and 9.7% of the patients who preferred another drug, if possible, cited religious reasons as the basis for this decision. Conclusions: Identifying the underlying factors contributing to low opioid use for pain management in MMC is important. Once the underlying factors were identified, all efforts should be taken to overcome them as they are barriers to improving patient pain management.


  1. Vallerand AH, Collins-Bohler D, Templin T, et al (2007). Knowledge of and barriers to pain management in caregivers of cancer patients receiving homecare. Cancer Nurs, 30, 31-7.
  2. Seya MJ, Gelders SF, Achara OU, et al (2011). A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother, 25, 6-18.
  3. Silberman M (2010). Opioids in Middle Eastern populations. Asian Pacific J Cancer Prev, 11 MECC Suppl, 1-5.
  4. Starr TD, Rogak LJ, Passik SD (2010). Substance abuse in cancer pain. Curr Pain Headache Rep, 14, 268-75.
  5. Van den Beuken-van Everdingen MH, deRijke JM, Kessels AG, et al (2007). Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol, 18, 1437-49.
  6. Von Roenn JH, Cleeland CS, Gonin R, et al (1993). Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med, 119, 121-6.
  7. Ward SE, Goldberg N, Miller-McCauley V, et al (1993). Patientrelated barriers to management of cancer pain. Pain, 52, 319-24.
  8. World Health Organization (1990). Cancer pain relief and palliative care. Technical Report Series 804. Geneva: WHO:
  9. Liang SY, Wang TJ, Wu SF, et al (2013). Gender differences associated with pain characteristics and treatment in Taiwanese oncology outpatients. Asian Pac J Cancer Prev, 14, 4077-82.
  10. Chen HC, Tang ST, Chen CH (2012). Meta-analysis of cultural differences in Western and Asian patient-perceived barriers to managing cancer pain. Palliat Med, 26, 206-21.
  11. Harford JB, Aljawi DM (2013). The need for more and better palliative care for Muslim patients. Palliat Support Care, 11, 1-4.
  12. Hojsted J, Sjogren P (2007). Addiction to opioids in chronic pain patients: A literature review. Eur J Pain, 11, 490-518.
  13. Maltoni M (2008). Opioids, pain and fear. Ann Oncol, 19, 5-7.
  14. Manchikanti L, Fellows B, Ailinani H, et al (2010). Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician, 13, 401-35.
  15. Meuser T, Pietruck C, Radbruch L, et al (2001). Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain, 93, 247-57.
  16. Portenoy RK (1995). Pharmacologic management of cancer pain. Semin Oncol, 22, 112-20.
  17. Reid CM, Gooberman-Hill R, Hanks GW (2008). Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Ann Oncol, 19, 44-8.
  18. Richmond C (2005). Dame Cicely Saunders. BMJ, 33, 238.
  19. Ripamonti CI, Santini D, Maranzano E, et al (2012). Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol, 23, 139-54.
  20. Al-Shahri MZ, Al-Khenaizan A (2005). Palliative care for Muslim patients. J Support Oncol, 3, 432-6.
  21. American Pain Society (1992). Principles of analgesic use in the treatment of cancer pain. 3rd edition. Skokie, IL: American Pain Society.
  22. Bardakoglu A (2004). "Moderate Perception of Islam and the Turkish Model of Diyanet: The President's Statement". J Muslim Minority Affairs, 24.
  23. Budkaew J, Chumworathayi B (2013). Knowledge and attitudes toward palliative terminal cancer care among Thai generalists. Asian Pac J Cancer Prev, 14, 6173-80

Cited by

  1. Mapping French people and health professionals’ positions regarding the circumstances of morphine use to relieve cancer pain vol.25, pp.9, 2017,
  2. Pain vol.126, pp.4, 2018,